The company's STAR platform consists of a family of endonuclease-based editing systems to produce cell therapy design candidates. Artisan Bio has validated the platform with T cells, induced pluripotent stem cells and cancer cells, as well as industrial cell lines like CHO and HEK293, it said.

CRISPR-based method can speed the identification of disease-causing genes
A new CRISPR gene editing screening method can be used to link phenotype and genotype in animal models. The method was efficiently deployed in zebrafish...